Cogent Biosciences
COGT
COGT
265 hedge funds and large institutions have $6.18B invested in Cogent Biosciences in 2025 Q4 according to their latest regulatory filings, with 94 funds opening new positions, 92 increasing their positions, 64 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% more funds holding
Funds holding: 194 → 265 (+71)
28% more call options, than puts
Call options by funds: $23.8M | Put options by funds: $18.6M
17.71% less ownership
Funds ownership: 139.85% → 122.14% (-18%)
Holders
265
Holding in Top 10
25
Calls
$23.8M
Puts
$18.6M
Top Buyers
| 1 | +$116M | |
| 2 | +$106M | |
| 3 | +$73.2M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$69.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$64.8M |
Top Sellers
| 1 | -$142M | |
| 2 | -$56.2M | |
| 3 | -$48.4M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$45.3M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$44.7M |
